Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...
The most recent trading session ended with Lucid Group (LCID) standing at $3.34, reflecting a -1.47% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...
Rising Dragon Acquisition Corp. (NASDAQ: RDAC) (the "Company") announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on ...